Epizyme IPO Research Information

Epizyme IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Epizyme, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Epizyme	EPZM - NASDAQ	$13.00-$15.00	$15.00	$20.00	5.9 million	5/31/2013
Underwriter(s): Citigroup, Cowen & Co., Leerink Swann
Co-Manager(s): JMP Securities, Wedbush PacGrow Life Sciences
Industry: Health Care
Filing(s): Filed 2013-04-18

Epizyme Quote & Chart - Click for current quote - EPZM

About Epizyme (adapted from Epizyme prospectus):
They are a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EPZM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.